 CAMBRIDGE, Mass.--BUSINESS WIRE--- SAGE Sage--Sage Therapeutics, Inc. NASDAQ: SAGE, a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that the Company will present at the following upcoming investor conferences: SVB Leerink Partners 10th Annual Global Healthcare Conference: on Thursday, February 25, 2021 at 8:00 am ET. Cowen Co. 41st Annual Health Care Conference: on Mond 